207 related articles for article (PubMed ID: 21323860)
1. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.
Chim CS; Wong KY; Leung CY; Chung LP; Hui PK; Chan SY; Yu L
J Cell Mol Med; 2011 Dec; 15(12):2760-7. PubMed ID: 21323860
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic inactivation of the miR-124-1 in haematological malignancies.
Wong KY; So CC; Loong F; Chung LP; Lam WW; Liang R; Li GK; Jin DY; Chim CS
PLoS One; 2011 Apr; 6(4):e19027. PubMed ID: 21544199
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of the MIR129-2 in hematological malignancies.
Wong KY; Yim RL; Kwong YL; Leung CY; Hui PK; Cheung F; Liang R; Jin DY; Chim CS
J Hematol Oncol; 2013 Feb; 6():16. PubMed ID: 23406679
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of the miR-34a in hematological malignancies.
Chim CS; Wong KY; Qi Y; Loong F; Lam WL; Wong LG; Jin DY; Costello JF; Liang R
Carcinogenesis; 2010 Apr; 31(4):745-50. PubMed ID: 20118199
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
Ng HY; Wan TS; So CC; Chim CS
J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
[TBL] [Abstract][Full Text] [Related]
7. miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration.
Zhang MY; Wang LQ; Chim CS
Cell Commun Signal; 2021 May; 19(1):62. PubMed ID: 34044822
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS
J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316
[TBL] [Abstract][Full Text] [Related]
9. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
Wang LQ; Wong KY; Rosèn A; Chim CS
Oncotarget; 2015 Dec; 6(42):44422-36. PubMed ID: 26517243
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
Wang LQ; Wong KY; Li ZH; Chim CS
Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
[TBL] [Abstract][Full Text] [Related]
13.
Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
[TBL] [Abstract][Full Text] [Related]
14. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker.
Anwar SL; Albat C; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
Int J Cancer; 2013 Aug; 133(3):660-70. PubMed ID: 23364900
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.
Lehmann U; Hasemeier B; Christgen M; Müller M; Römermann D; Länger F; Kreipe H
J Pathol; 2008 Jan; 214(1):17-24. PubMed ID: 17948228
[TBL] [Abstract][Full Text] [Related]
16. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.
Tanaka N; Toyooka S; Soh J; Kubo T; Yamamoto H; Maki Y; Muraoka T; Shien K; Furukawa M; Ueno T; Asano H; Tsukuda K; Aoe K; Miyoshi S
Lung Cancer; 2012 Apr; 76(1):32-8. PubMed ID: 22047961
[TBL] [Abstract][Full Text] [Related]
17. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.
Wilting SM; van Boerdonk RA; Henken FE; Meijer CJ; Diosdado B; Meijer GA; le Sage C; Agami R; Snijders PJ; Steenbergen RD
Mol Cancer; 2010 Jun; 9():167. PubMed ID: 20579385
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
[TBL] [Abstract][Full Text] [Related]
19. Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.
Chim CS; Wan TS; Wong KY; Fung TK; Drexler HG; Wong KF
J Transl Med; 2011 Nov; 9():197. PubMed ID: 22082000
[TBL] [Abstract][Full Text] [Related]
20. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
Ying J; Gao Z; Li H; Srivastava G; Murray PG; Goh HK; Lim CY; Wang Y; Marafioti T; Mason DY; Ambinder RF; Chan AT; Tao Q
Br J Haematol; 2007 Mar; 136(6):829-32. PubMed ID: 17341268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
